High-dose PRP and standard PRP are not the same product. Standard single-spin PRP concentrates platelets about 2 to 3 times baseline. High-Dose Dynamic PRP+ at Dynamic Athlete uses multi-spin processing to reach 12 to 20 times baseline, over 10 billion platelets, with Exosome-Containing Fibrin-Rich Plasma, under live ultrasound, by Dr. Garg. Platelets carry the growth factors that drive healing, so dose is one of the variables most likely to decide whether PRP does anything. Both share the label. They are not interchangeable, and the price rarely tells you which one you are getting.
If you have read that “PRP does not work,” you have probably read about under-dosed PRP. This page explains why the studies disagree, why so many treatments fail active adults, and what a physician changes when dose, delivery, and staging are controlled.
Why platelet dose decides the result
Platelets carry the growth factors that drive a healing response. How many you deliver to the tissue is one of the variables most likely to decide whether anything happens.
A 2 to 3 times injection is a thin product
A basic single-spin kit concentrates platelets only 2 to 3 times your blood baseline. That is what many clinics deliver under the name PRP. There is a concentration window where dose appears to matter for the healing response, and a thin preparation can fall short of it. High-Dose Dynamic PRP+ uses multi-spin processing to reach 12 to 20 times baseline, over 10 billion platelets.
It is why the studies disagree
PRP can look like it works in one trial and fails in another largely because of how it was prepared. A systematic review found that many PRP studies do not even report the platelet dose they injected. When the input is undefined and inconsistent, the output looks inconsistent. The headline “does PRP work” is the wrong question; “what dose, placed where” is the right one.
The dose needs a scaffold and a target
Dose alone is not the whole story. Exosome-Containing Fibrin-Rich Plasma forms a matrix that helps hold the biologic where it is placed for a more sustained release, and live ultrasound puts it on the actual target tissue rather than near it. A strong dose, a scaffold, and precise placement are a coherent strategy. A thin dose placed blind is not.
The physician stages it against the problem
High-dose is not a slogan or a single magic number. Dr. Garg sets the protocol to the tissue: High-Dose Dynamic PRP+ for many tendon and early-stage joint problems, shockwave priming when indicated, and staging toward Dynamic Stem Cell+ for a more degenerated joint. The point is to remove dose, delivery, and staging as failure points, not to promise an outcome.
Standard PRP and High-Dose PRP, side by side
Both are autologous and both use your own blood. Here is where they part.
| Variable | Standard PRP | High-Dose Dynamic PRP+ |
|---|---|---|
| Platelet concentration | About 2 to 3 times baseline | 12 to 20 times baseline, over 10 billion |
| Processing | Basic single-spin kit | Multi-spin protocol |
| Scaffold | Typically none | Exosome-Containing Fibrin-Rich Plasma |
| Guidance | Often blind or landmark-based | Live ultrasound, every injection |
| Who performs it | Often a technician or mid-level | Dr. Garg, every time |
The line that matters
The device, the kit, and the word are not what decides a PRP result. The dose, the delivery, and who is making the staging call are. A low price most often buys away the first two.
Three questions that reveal the dose
The label does not distinguish a 2 to 3 times product from a 12 to 20 times product. These do. A clinic that controls its process can answer all three.
Print this. Ask it before you book.
- What platelet concentration do you target? “12 to 20 times baseline” is a specific, checkable answer; “PRP” and a price is not.
- Do you add a fibrin scaffold, and is the injection placed under live ultrasound? A scaffold and a target are how the dose holds and lands.
- Who performs the injection, and will you stage it if the tissue needs more? The physician, and yes, are the answers you want.
Frequently asked questions
What is the difference between high-dose PRP and standard PRP?
The difference is platelet concentration, and it is large enough that they are effectively different products. Standard PRP, usually made with a basic single-spin kit, concentrates platelets about 2 to 3 times your blood baseline. High-Dose Dynamic PRP+ at Dynamic Athlete uses multi-spin processing to reach 12 to 20 times baseline, over 10 billion platelets, and adds Exosome-Containing Fibrin-Rich Plasma as a scaffold. Platelets carry the growth factors that drive a healing response, so the number of platelets delivered to the tissue is one of the variables most likely to change whether the treatment does anything. Both are called PRP, both are autologous, and both use your own blood. But a 2 to 3 times injection and a 12 to 20 times injection are not interchangeable, and the price and the label rarely tell you which one you are getting.
Why do published PRP studies disagree about whether PRP works?
Because they are often not studying the same product. Platelet dose, the spin protocol, leukocyte content, the number of injections, and the use of imaging guidance vary enormously across trials, and a systematic review found that many PRP studies do not even report the platelet dose they injected. When the input is undefined and inconsistent, the output looks inconsistent, and PRP can appear to work in one trial and fail in another largely because of how it was prepared and delivered. This is why a blanket does PRP work question is hard to answer from the headlines. The more useful questions are what dose was used, where it was placed, and who placed it. Emerging evidence links higher, well-characterized platelet doses to better outcomes for several indications, which is the rationale behind a high-dose protocol.
Why does so much PRP fail active adults?
When PRP does not deliver for an active adult, the cause is usually execution rather than the concept. The three most common failure points are an under-dosed preparation, a blind injection that does not reach the target tissue, and a single treatment used where the problem needed staging. A 2 to 3 times concentration dropped near a joint without ultrasound is a thin product placed imprecisely, and active adults loading the tissue hard are exactly the people who feel the shortfall. At Dynamic Athlete, the response is High-Dose Dynamic PRP+ at 12 to 20 times baseline, placed under live ultrasound by Dr. Aneesh Garg, DO, CAQ, with shockwave priming or staging toward stem cell therapy when the tissue calls for it. PRP is not a guarantee, but controlling dose, delivery, and staging is how a clinic controls the variables that decide the result.
Is more platelets always better?
Not in a simple linear way, and any clinic claiming a single magic number is overselling. The relationship between platelet dose and outcome is an active area of research, and there is a window where concentration appears to matter for the healing response, below which the dose may be too thin to do much. The point of a high-dose protocol is not to chase the largest possible number for its own sake; it is to reliably land inside the range the evidence suggests is meaningful, rather than the 2 to 3 times a basic kit happens to produce. Other variables, the fibrin scaffold, leukocyte content, injection accuracy, and how the course is staged, all still matter. Dose is one lever, an important one, and it is the lever a low-cost single-spin product most often gives up. Dr. Garg sets the protocol to the tissue, not to a slogan.
What is Fibrin-Rich Plasma, and why is it added?
Exosome-Containing Fibrin-Rich Plasma is a fibrin-based preparation that is co-delivered with High-Dose Dynamic PRP+. Fibrin forms a matrix, a scaffold, that helps hold the biologic material where it is placed and supports a more sustained release of growth factors rather than a single rapid burst. In practical terms, the platelets supply the signal and the fibrin helps keep that signal at the target tissue over time instead of dispersing immediately. This is part of why dose and delivery are discussed together at Dynamic Athlete: a strong dose placed precisely under ultrasound, with a scaffold to keep it in place, is a coherent biologic strategy. A thin, single-spin injection without a scaffold, placed blind, is a different and weaker approach. The fibrin component is one more variable that a bare standard-PRP product typically omits.
Who performs Dynamic PRP+, and why does that matter?
All Dynamic PRP+ procedures are performed exclusively by Dr. Aneesh Garg, DO, CAQ. He is double board-certified in Sports Medicine and Internal Medicine, Yale-New Haven Hospital trained, an Andrews Sports Medicine fellowship graduate, Teaching Faculty at the Regenerative Medicine Training Institute and Rocky Vista University, and a team physician for USA Hockey and U.S. Soccer. He also founded the American Shockwave Training Institute. This matters because the variables that decide a PRP result, the dose, the fibrin scaffold, the exact ultrasound-guided placement, and whether the course should be staged with shockwave or escalated to stem cell therapy, are physician decisions. At many clinics, the injection is delegated to a technician or mid-level provider using whatever the standard kit produces. At Dynamic Athlete, the physician who teaches other doctors regenerative technique performs your procedure himself.
Does high-dose PRP work better than standard PRP?
The honest answer is that dose is one of the strongest candidate explanations for why PRP results vary, and emerging evidence links higher, well-characterized platelet doses to better clinical outcomes for several indications, but PRP is not a guarantee and no clinic should promise one. What a high-dose protocol does is remove dose as a likely failure point, then pair it with precise ultrasound-guided placement and physician staging so the other failure points are controlled too. At Dynamic Athlete, over 90% of our patients self-report a 75% or greater improvement, all without surgery. That figure is self-reported, not a guarantee, and your candidacy and likely response are assessed individually at evaluation. The argument for High-Dose Dynamic PRP+ is not a promise; it is that controlling dose, delivery, and staging is how you control the variables that decide the outcome.
How do I know what platelet dose a clinic actually delivers?
You ask, and you treat the answer as diagnostic. A clinic that controls its process can tell you the approximate platelet concentration it targets, the spin protocol it uses, whether it adds a fibrin component, and whether the injection is placed under live ultrasound. A clinic that cannot answer, or that answers only with the word PRP and a price, is telling you the dose is whatever the kit happened to produce, often 2 to 3 times baseline. Dynamic Athlete targets 12 to 20 times baseline, over 10 billion platelets, with Exosome-Containing Fibrin-Rich Plasma, under ultrasound, by the physician. Those are specific, checkable claims. The purpose of asking is not to embarrass anyone; it is to make sure the product you are paying for is the product you think you are paying for, because the label does not distinguish them.
Get the dose your tissue actually needs
Imaging-based diagnosis, then the Dynamic PRP+ high-dose protocol under live ultrasound, by Dr. Garg, with staging toward stem cell therapy when the joint calls for it.